FOAMIX PHARMACEUTICALS LTD's ticker is and the CUSIP is M46135955. A total of 1 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $159,000 | +2550.0% | 47,700 | +2550.0% | 0.00% | – |
| Q4 2018 | $6,000 | -93.0% | 1,800 | -88.0% | 0.00% | -100.0% |
| Q3 2018 | $86,000 | +218.5% | 15,000 | +183.0% | 0.00% | – |
| Q2 2018 | $27,000 | -41.3% | 5,300 | -47.0% | 0.00% | – |
| Q2 2017 | $46,000 | +15.0% | 10,000 | +23.5% | 0.00% | – |
| Q1 2017 | $40,000 | – | 8,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |